Skip to content

Clinical trials

Observational Candidiasis, Vulvovaginal trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Candidiasis, Vulvovaginal Phase: Observational Clear all

15 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20101
20131
20141
20162
20181
20201
20212
20222
20242
20252

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed10
Active, not recruiting2
Not yet recruiting1
Recruiting1
Terminated1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Bayer2
Ankara City Hospital Bilkent1
Beijing Tsinghua Chang Gung Hospital1
Cidara Therapeutics Inc., a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA)1
Gedea Biotech AB1
GlaxoSmithKline1
Hoffmann-La Roche1
Janneke van de Wijgert1
Meir Medical Center1
National Institute of Allergy and Infectious Diseases (NIAID)1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Candidiasis, Vulvovaginal15
Vaginosis, Bacterial6
Trichomonas Vaginitis3
Communicable Diseases2
Sexually Transmitted Diseases2
Atrophic Vaginitis1
Candidiasis1
Candidiasis, Oral1
Dyspareunia1
Gonorrhea1

Trials

Showing 1 to 15 of 15. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.